Details

Autor(en) / Beteiligte

• Starska, Katarzyna
• Forma, Ewa
• Jóźwiak, Paweł
• Lewy-Trenda, Iwona
• Danilewicz, Marian
• Stasikowska-Kanicka, Olga
• Skóra, Michał
• Kolary, Katarzyna
• Miazga, Jakub
• Krześlak, Anna
• Bryś, Magdalena

Titel

Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer

Ist Teil von

• Tumor biology, 2016-10, Vol.37 (10), p.13185-13203

Ort / Verlag

Dordrecht: Springer Netherlands

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• Recent evidence indicates the involvement of calpains (CAPNs), a family of cysteine proteases, in cancer development and progression, as well as the insufficient response to cancer therapies. The contribution of CAPNs and regulatory calpastatin (CAST) and ERK1/2 kinases to aggressiveness, disease course, and outcome in laryngeal cancer remains elusive. This study was aimed to evaluate the CAPN1/2-CAST-ERK1/2 enzyme system mRNA/protein level and to investigate whether they can promote the dynamic of tumor growth and prognosis. The mRNA expression of marker genes was determined in 106 laryngeal cancer (SCLC) cases and 73 non-cancerous adjacent mucosa (NCLM) controls using quantitative real-time PCR. The level of corresponding proteins was analyzed by Western Blot. SLUG expression, as indicator of pathological advancement was determined using IHC staining. Significant increases of CAPN1/2-CAST-ERK1/2 levels of mRNA/protein were noted in SCLC compared to NCLM ( p  < 0.05). As a result, a higher level of CAPN1 and ERK1 genes was related to larger tumor size, more aggressive and deeper growth according to TFG scale and SLUG level ( p  < 0.05). There were also relationships of CAPN1/2 and ERK1 with incidences of local/nodal recurrences ( p  < 0.05). An inverse association for CAPN1/2 , CAST , and ERK1/2 transcripts was determined with regard to overall survival ( p  < 0.05). In addition, a higher CAPN1 and phospho-ERK1 protein level was related to higher grade and stage ( p  < 0.05) and was found to promote worse prognosis. This is the first study to show that activity of CAPN1/2- CAST-ERK1/2 axis may be an indicator of tumor phenotype and unfavorable outcome in SCLC.